nodes	percent_of_prediction	percent_of_DWPC	metapath
Gonadorelin—Icatibant—BDKRB2—coronary artery disease	0.016	0.617	CrCbGaD
Gonadorelin—Terlipressin—AVPR1A—coronary artery disease	0.00528	0.203	CrCbGaD
Gonadorelin—Desmopressin—AVPR1A—coronary artery disease	0.00414	0.159	CrCbGaD
Gonadorelin—Abdominal pain—Clopidogrel—coronary artery disease	0.00101	0.00166	CcSEcCtD
Gonadorelin—Shock—Telmisartan—coronary artery disease	0.00101	0.00166	CcSEcCtD
Gonadorelin—Nervous system disorder—Telmisartan—coronary artery disease	0.00101	0.00165	CcSEcCtD
Gonadorelin—Abdominal pain—Lovastatin—coronary artery disease	0.00101	0.00165	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Eplerenone—coronary artery disease	0.000998	0.00164	CcSEcCtD
Gonadorelin—Anaphylactic shock—Captopril—coronary artery disease	0.000997	0.00164	CcSEcCtD
Gonadorelin—Diarrhoea—Acetylsalicylic acid—coronary artery disease	0.000997	0.00164	CcSEcCtD
Gonadorelin—Immune system disorder—Ramipril—coronary artery disease	0.00099	0.00163	CcSEcCtD
Gonadorelin—Nausea—Ticagrelor—coronary artery disease	0.00099	0.00163	CcSEcCtD
Gonadorelin—Abdominal pain—Ezetimibe—coronary artery disease	0.000986	0.00162	CcSEcCtD
Gonadorelin—Shock—Captopril—coronary artery disease	0.000981	0.00161	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Simvastatin—coronary artery disease	0.000972	0.0016	CcSEcCtD
Gonadorelin—Angiopathy—Timolol—coronary artery disease	0.000972	0.0016	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Valsartan—coronary artery disease	0.00097	0.00159	CcSEcCtD
Gonadorelin—Anaphylactic shock—Perindopril—coronary artery disease	0.000968	0.00159	CcSEcCtD
Gonadorelin—Fatigue—Valsartan—coronary artery disease	0.000968	0.00159	CcSEcCtD
Gonadorelin—Immune system disorder—Timolol—coronary artery disease	0.000968	0.00159	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Olmesartan—coronary artery disease	0.000965	0.00158	CcSEcCtD
Gonadorelin—Abdominal pain—Eplerenone—coronary artery disease	0.000965	0.00158	CcSEcCtD
Gonadorelin—Fatigue—Olmesartan—coronary artery disease	0.000964	0.00158	CcSEcCtD
Gonadorelin—Constipation—Valsartan—coronary artery disease	0.00096	0.00158	CcSEcCtD
Gonadorelin—Hypersensitivity—Fenofibrate—coronary artery disease	0.000959	0.00158	CcSEcCtD
Gonadorelin—Constipation—Olmesartan—coronary artery disease	0.000956	0.00157	CcSEcCtD
Gonadorelin—Pain—Olmesartan—coronary artery disease	0.000956	0.00157	CcSEcCtD
Gonadorelin—Erythema—Ramipril—coronary artery disease	0.000954	0.00157	CcSEcCtD
Gonadorelin—Shock—Perindopril—coronary artery disease	0.000953	0.00156	CcSEcCtD
Gonadorelin—Nervous system disorder—Perindopril—coronary artery disease	0.00095	0.00156	CcSEcCtD
Gonadorelin—Hypersensitivity—Clopidogrel—coronary artery disease	0.000943	0.00155	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Niacin—coronary artery disease	0.000943	0.00155	CcSEcCtD
Gonadorelin—Anaphylactic shock—Furosemide—coronary artery disease	0.000941	0.00155	CcSEcCtD
Gonadorelin—Abdominal pain—Simvastatin—coronary artery disease	0.00094	0.00154	CcSEcCtD
Gonadorelin—Headache—Rosuvastatin—coronary artery disease	0.00094	0.00154	CcSEcCtD
Gonadorelin—Hypersensitivity—Lovastatin—coronary artery disease	0.000937	0.00154	CcSEcCtD
Gonadorelin—Asthenia—Fenofibrate—coronary artery disease	0.000934	0.00153	CcSEcCtD
Gonadorelin—Pain—Niacin—coronary artery disease	0.000934	0.00153	CcSEcCtD
Gonadorelin—Erythema—Timolol—coronary artery disease	0.000933	0.00153	CcSEcCtD
Gonadorelin—Fatigue—Pravastatin—coronary artery disease	0.000927	0.00152	CcSEcCtD
Gonadorelin—Vomiting—Acetylsalicylic acid—coronary artery disease	0.000927	0.00152	CcSEcCtD
Gonadorelin—Shock—Furosemide—coronary artery disease	0.000926	0.00152	CcSEcCtD
Gonadorelin—Nervous system disorder—Furosemide—coronary artery disease	0.000923	0.00152	CcSEcCtD
Gonadorelin—Pruritus—Fenofibrate—coronary artery disease	0.000921	0.00151	CcSEcCtD
Gonadorelin—Pain—Pravastatin—coronary artery disease	0.000919	0.00151	CcSEcCtD
Gonadorelin—Constipation—Pravastatin—coronary artery disease	0.000919	0.00151	CcSEcCtD
Gonadorelin—Hypersensitivity—Ezetimibe—coronary artery disease	0.000919	0.00151	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Valsartan—coronary artery disease	0.000918	0.00151	CcSEcCtD
Gonadorelin—Asthenia—Clopidogrel—coronary artery disease	0.000918	0.00151	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Olmesartan—coronary artery disease	0.000914	0.0015	CcSEcCtD
Gonadorelin—Asthenia—Lovastatin—coronary artery disease	0.000912	0.0015	CcSEcCtD
Gonadorelin—Anaphylactic shock—Losartan—coronary artery disease	0.000908	0.00149	CcSEcCtD
Gonadorelin—Pruritus—Clopidogrel—coronary artery disease	0.000906	0.00149	CcSEcCtD
Gonadorelin—Angiopathy—Lisinopril—coronary artery disease	0.000902	0.00148	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Trandolapril—coronary artery disease	0.000901	0.00148	CcSEcCtD
Gonadorelin—Fatigue—Trandolapril—coronary artery disease	0.0009	0.00148	CcSEcCtD
Gonadorelin—Pruritus—Lovastatin—coronary artery disease	0.000899	0.00148	CcSEcCtD
Gonadorelin—Fatigue—Enalapril—coronary artery disease	0.000897	0.00147	CcSEcCtD
Gonadorelin—Asthenia—Ezetimibe—coronary artery disease	0.000895	0.00147	CcSEcCtD
Gonadorelin—Shock—Losartan—coronary artery disease	0.000894	0.00147	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Niacin—coronary artery disease	0.000893	0.00147	CcSEcCtD
Gonadorelin—Constipation—Trandolapril—coronary artery disease	0.000893	0.00147	CcSEcCtD
Gonadorelin—Nausea—Rosuvastatin—coronary artery disease	0.000891	0.00146	CcSEcCtD
Gonadorelin—Diarrhoea—Fenofibrate—coronary artery disease	0.000891	0.00146	CcSEcCtD
Gonadorelin—Nervous system disorder—Losartan—coronary artery disease	0.000891	0.00146	CcSEcCtD
Gonadorelin—Constipation—Enalapril—coronary artery disease	0.000889	0.00146	CcSEcCtD
Gonadorelin—Abdominal pain—Valsartan—coronary artery disease	0.000888	0.00146	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Telmisartan—coronary artery disease	0.000885	0.00145	CcSEcCtD
Gonadorelin—Fatigue—Telmisartan—coronary artery disease	0.000884	0.00145	CcSEcCtD
Gonadorelin—Abdominal pain—Olmesartan—coronary artery disease	0.000884	0.00145	CcSEcCtD
Gonadorelin—Pruritus—Ezetimibe—coronary artery disease	0.000882	0.00145	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Pravastatin—coronary artery disease	0.000879	0.00144	CcSEcCtD
Gonadorelin—Constipation—Telmisartan—coronary artery disease	0.000877	0.00144	CcSEcCtD
Gonadorelin—Pain—Telmisartan—coronary artery disease	0.000877	0.00144	CcSEcCtD
Gonadorelin—Hypersensitivity—Simvastatin—coronary artery disease	0.000876	0.00144	CcSEcCtD
Gonadorelin—Diarrhoea—Clopidogrel—coronary artery disease	0.000876	0.00144	CcSEcCtD
Gonadorelin—Asthenia—Eplerenone—coronary artery disease	0.000876	0.00144	CcSEcCtD
Gonadorelin—Diarrhoea—Lovastatin—coronary artery disease	0.00087	0.00143	CcSEcCtD
Gonadorelin—Nausea—Acetylsalicylic acid—coronary artery disease	0.000866	0.00142	CcSEcCtD
Gonadorelin—Erythema—Lisinopril—coronary artery disease	0.000865	0.00142	CcSEcCtD
Gonadorelin—Pruritus—Eplerenone—coronary artery disease	0.000864	0.00142	CcSEcCtD
Gonadorelin—Abdominal pain—Niacin—coronary artery disease	0.000863	0.00142	CcSEcCtD
Gonadorelin—Fatigue—Captopril—coronary artery disease	0.00086	0.00141	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Trandolapril—coronary artery disease	0.000854	0.0014	CcSEcCtD
Gonadorelin—Asthenia—Simvastatin—coronary artery disease	0.000853	0.0014	CcSEcCtD
Gonadorelin—Diarrhoea—Ezetimibe—coronary artery disease	0.000853	0.0014	CcSEcCtD
Gonadorelin—Constipation—Captopril—coronary artery disease	0.000853	0.0014	CcSEcCtD
Gonadorelin—Flatulence—Lisinopril—coronary artery disease	0.000853	0.0014	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Enalapril—coronary artery disease	0.00085	0.0014	CcSEcCtD
Gonadorelin—Abdominal pain—Pravastatin—coronary artery disease	0.00085	0.0014	CcSEcCtD
Gonadorelin—Pruritus—Simvastatin—coronary artery disease	0.000841	0.00138	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Telmisartan—coronary artery disease	0.000839	0.00138	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Perindopril—coronary artery disease	0.000836	0.00137	CcSEcCtD
Gonadorelin—Diarrhoea—Eplerenone—coronary artery disease	0.000835	0.00137	CcSEcCtD
Gonadorelin—Fatigue—Perindopril—coronary artery disease	0.000835	0.00137	CcSEcCtD
Gonadorelin—Constipation—Perindopril—coronary artery disease	0.000828	0.00136	CcSEcCtD
Gonadorelin—Pain—Perindopril—coronary artery disease	0.000828	0.00136	CcSEcCtD
Gonadorelin—Vomiting—Fenofibrate—coronary artery disease	0.000828	0.00136	CcSEcCtD
Gonadorelin—Hypersensitivity—Valsartan—coronary artery disease	0.000827	0.00136	CcSEcCtD
Gonadorelin—Abdominal pain—Trandolapril—coronary artery disease	0.000825	0.00136	CcSEcCtD
Gonadorelin—Abdominal pain—Enalapril—coronary artery disease	0.000822	0.00135	CcSEcCtD
Gonadorelin—Headache—Fenofibrate—coronary artery disease	0.000816	0.00134	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Captopril—coronary artery disease	0.000816	0.00134	CcSEcCtD
Gonadorelin—Vomiting—Clopidogrel—coronary artery disease	0.000814	0.00134	CcSEcCtD
Gonadorelin—Diarrhoea—Simvastatin—coronary artery disease	0.000814	0.00134	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Furosemide—coronary artery disease	0.000813	0.00133	CcSEcCtD
Gonadorelin—Fatigue—Furosemide—coronary artery disease	0.000812	0.00133	CcSEcCtD
Gonadorelin—Abdominal pain—Telmisartan—coronary artery disease	0.000811	0.00133	CcSEcCtD
Gonadorelin—Vomiting—Lovastatin—coronary artery disease	0.000808	0.00133	CcSEcCtD
Gonadorelin—Asthenia—Valsartan—coronary artery disease	0.000806	0.00132	CcSEcCtD
Gonadorelin—Pain—Furosemide—coronary artery disease	0.000805	0.00132	CcSEcCtD
Gonadorelin—Constipation—Furosemide—coronary artery disease	0.000805	0.00132	CcSEcCtD
Gonadorelin—Hypersensitivity—Niacin—coronary artery disease	0.000804	0.00132	CcSEcCtD
Gonadorelin—Asthenia—Olmesartan—coronary artery disease	0.000802	0.00132	CcSEcCtD
Gonadorelin—Headache—Clopidogrel—coronary artery disease	0.000802	0.00132	CcSEcCtD
Gonadorelin—Headache—Lovastatin—coronary artery disease	0.000796	0.00131	CcSEcCtD
Gonadorelin—Pruritus—Valsartan—coronary artery disease	0.000795	0.0013	CcSEcCtD
Gonadorelin—Vomiting—Ezetimibe—coronary artery disease	0.000793	0.0013	CcSEcCtD
Gonadorelin—Hypersensitivity—Pravastatin—coronary artery disease	0.000792	0.0013	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Perindopril—coronary artery disease	0.000792	0.0013	CcSEcCtD
Gonadorelin—Pruritus—Olmesartan—coronary artery disease	0.000791	0.0013	CcSEcCtD
Gonadorelin—Abdominal pain—Captopril—coronary artery disease	0.000788	0.00129	CcSEcCtD
Gonadorelin—Asthenia—Niacin—coronary artery disease	0.000783	0.00129	CcSEcCtD
Gonadorelin—Fatigue—Losartan—coronary artery disease	0.000783	0.00129	CcSEcCtD
Gonadorelin—Headache—Ezetimibe—coronary artery disease	0.000781	0.00128	CcSEcCtD
Gonadorelin—Anaphylactic shock—Ramipril—coronary artery disease	0.000779	0.00128	CcSEcCtD
Gonadorelin—Constipation—Losartan—coronary artery disease	0.000777	0.00128	CcSEcCtD
Gonadorelin—Pain—Losartan—coronary artery disease	0.000777	0.00128	CcSEcCtD
Gonadorelin—Vomiting—Eplerenone—coronary artery disease	0.000776	0.00127	CcSEcCtD
Gonadorelin—Nausea—Fenofibrate—coronary artery disease	0.000773	0.00127	CcSEcCtD
Gonadorelin—Pruritus—Niacin—coronary artery disease	0.000773	0.00127	CcSEcCtD
Gonadorelin—Asthenia—Pravastatin—coronary artery disease	0.000771	0.00127	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Furosemide—coronary artery disease	0.00077	0.00126	CcSEcCtD
Gonadorelin—Hypersensitivity—Trandolapril—coronary artery disease	0.000769	0.00126	CcSEcCtD
Gonadorelin—Diarrhoea—Valsartan—coronary artery disease	0.000768	0.00126	CcSEcCtD
Gonadorelin—Shock—Ramipril—coronary artery disease	0.000766	0.00126	CcSEcCtD
Gonadorelin—Hypersensitivity—Enalapril—coronary artery disease	0.000766	0.00126	CcSEcCtD
Gonadorelin—Abdominal pain—Perindopril—coronary artery disease	0.000765	0.00126	CcSEcCtD
Gonadorelin—Diarrhoea—Olmesartan—coronary artery disease	0.000765	0.00126	CcSEcCtD
Gonadorelin—Headache—Eplerenone—coronary artery disease	0.000765	0.00126	CcSEcCtD
Gonadorelin—Nervous system disorder—Ramipril—coronary artery disease	0.000764	0.00125	CcSEcCtD
Gonadorelin—Anaphylactic shock—Timolol—coronary artery disease	0.000761	0.00125	CcSEcCtD
Gonadorelin—Pruritus—Pravastatin—coronary artery disease	0.000761	0.00125	CcSEcCtD
Gonadorelin—Nausea—Clopidogrel—coronary artery disease	0.00076	0.00125	CcSEcCtD
Gonadorelin—Vomiting—Simvastatin—coronary artery disease	0.000756	0.00124	CcSEcCtD
Gonadorelin—Hypersensitivity—Telmisartan—coronary artery disease	0.000756	0.00124	CcSEcCtD
Gonadorelin—Nausea—Lovastatin—coronary artery disease	0.000755	0.00124	CcSEcCtD
Gonadorelin—Asthenia—Trandolapril—coronary artery disease	0.000749	0.00123	CcSEcCtD
Gonadorelin—Shock—Timolol—coronary artery disease	0.000749	0.00123	CcSEcCtD
Gonadorelin—Diarrhoea—Niacin—coronary artery disease	0.000747	0.00123	CcSEcCtD
Gonadorelin—Nervous system disorder—Timolol—coronary artery disease	0.000747	0.00123	CcSEcCtD
Gonadorelin—Asthenia—Enalapril—coronary artery disease	0.000746	0.00123	CcSEcCtD
Gonadorelin—Headache—Simvastatin—coronary artery disease	0.000745	0.00122	CcSEcCtD
Gonadorelin—Abdominal pain—Furosemide—coronary artery disease	0.000744	0.00122	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Losartan—coronary artery disease	0.000743	0.00122	CcSEcCtD
Gonadorelin—Nausea—Ezetimibe—coronary artery disease	0.000741	0.00122	CcSEcCtD
Gonadorelin—Pruritus—Trandolapril—coronary artery disease	0.000739	0.00121	CcSEcCtD
Gonadorelin—Asthenia—Telmisartan—coronary artery disease	0.000736	0.00121	CcSEcCtD
Gonadorelin—Pruritus—Enalapril—coronary artery disease	0.000736	0.00121	CcSEcCtD
Gonadorelin—Diarrhoea—Pravastatin—coronary artery disease	0.000736	0.00121	CcSEcCtD
Gonadorelin—Pruritus—Telmisartan—coronary artery disease	0.000726	0.00119	CcSEcCtD
Gonadorelin—Nausea—Eplerenone—coronary artery disease	0.000725	0.00119	CcSEcCtD
Gonadorelin—GNRHR—Signaling by GPCR—PPBP—coronary artery disease	0.000722	0.00198	CbGpPWpGaD
Gonadorelin—Abdominal pain—Losartan—coronary artery disease	0.000718	0.00118	CcSEcCtD
Gonadorelin—Asthenia—Captopril—coronary artery disease	0.000716	0.00118	CcSEcCtD
Gonadorelin—Diarrhoea—Trandolapril—coronary artery disease	0.000714	0.00117	CcSEcCtD
Gonadorelin—Vomiting—Valsartan—coronary artery disease	0.000714	0.00117	CcSEcCtD
Gonadorelin—Diarrhoea—Enalapril—coronary artery disease	0.000711	0.00117	CcSEcCtD
Gonadorelin—Vomiting—Olmesartan—coronary artery disease	0.000711	0.00117	CcSEcCtD
Gonadorelin—GNRHR—GPCR ligand binding—KNG1—coronary artery disease	0.00071	0.00194	CbGpPWpGaD
Gonadorelin—Nausea—Simvastatin—coronary artery disease	0.000706	0.00116	CcSEcCtD
Gonadorelin—Anaphylactic shock—Lisinopril—coronary artery disease	0.000706	0.00116	CcSEcCtD
Gonadorelin—Pruritus—Captopril—coronary artery disease	0.000706	0.00116	CcSEcCtD
Gonadorelin—GNRHR—GPCR ligand binding—AGTR1—coronary artery disease	0.000705	0.00193	CbGpPWpGaD
Gonadorelin—Headache—Valsartan—coronary artery disease	0.000704	0.00116	CcSEcCtD
Gonadorelin—Diarrhoea—Telmisartan—coronary artery disease	0.000702	0.00115	CcSEcCtD
Gonadorelin—GNRHR—GPCR downstream signaling—AVPR1A—coronary artery disease	0.0007	0.00192	CbGpPWpGaD
Gonadorelin—Headache—Olmesartan—coronary artery disease	0.0007	0.00115	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—ADM2—coronary artery disease	0.000699	0.00191	CbGpPWpGaD
Gonadorelin—Shock—Lisinopril—coronary artery disease	0.000695	0.00114	CcSEcCtD
Gonadorelin—Asthenia—Perindopril—coronary artery disease	0.000695	0.00114	CcSEcCtD
Gonadorelin—Vomiting—Niacin—coronary artery disease	0.000694	0.00114	CcSEcCtD
Gonadorelin—Hypersensitivity—Furosemide—coronary artery disease	0.000694	0.00114	CcSEcCtD
Gonadorelin—GNRHR—GPCR ligand binding—CXCL10—coronary artery disease	0.000689	0.00189	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—OPRD1—coronary artery disease	0.000689	0.00189	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—CCL4—coronary artery disease	0.000689	0.00189	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—HTR2A—coronary artery disease	0.000687	0.00188	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—C3—coronary artery disease	0.000686	0.00188	CbGpPWpGaD
Gonadorelin—Pruritus—Perindopril—coronary artery disease	0.000685	0.00113	CcSEcCtD
Gonadorelin—Headache—Niacin—coronary artery disease	0.000684	0.00112	CcSEcCtD
Gonadorelin—Vomiting—Pravastatin—coronary artery disease	0.000684	0.00112	CcSEcCtD
Gonadorelin—Diarrhoea—Captopril—coronary artery disease	0.000682	0.00112	CcSEcCtD
Gonadorelin—GNRHR—GPCR downstream signaling—UTS2—coronary artery disease	0.000676	0.00185	CbGpPWpGaD
Gonadorelin—Asthenia—Furosemide—coronary artery disease	0.000675	0.00111	CcSEcCtD
Gonadorelin—Headache—Pravastatin—coronary artery disease	0.000674	0.00111	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Ramipril—coronary artery disease	0.000672	0.0011	CcSEcCtD
Gonadorelin—Fatigue—Ramipril—coronary artery disease	0.000671	0.0011	CcSEcCtD
Gonadorelin—GNRHR—GPCR ligand binding—ADRB2—coronary artery disease	0.000669	0.00183	CbGpPWpGaD
Gonadorelin—Hypersensitivity—Losartan—coronary artery disease	0.000669	0.0011	CcSEcCtD
Gonadorelin—Nausea—Valsartan—coronary artery disease	0.000667	0.0011	CcSEcCtD
Gonadorelin—Pruritus—Furosemide—coronary artery disease	0.000666	0.00109	CcSEcCtD
Gonadorelin—Constipation—Ramipril—coronary artery disease	0.000666	0.00109	CcSEcCtD
Gonadorelin—Nausea—Olmesartan—coronary artery disease	0.000664	0.00109	CcSEcCtD
Gonadorelin—Vomiting—Trandolapril—coronary artery disease	0.000664	0.00109	CcSEcCtD
Gonadorelin—Diarrhoea—Perindopril—coronary artery disease	0.000663	0.00109	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—TMED2—coronary artery disease	0.000662	0.00181	CbGpPWpGaD
Gonadorelin—Vomiting—Enalapril—coronary artery disease	0.000661	0.00109	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Timolol—coronary artery disease	0.000657	0.00108	CcSEcCtD
Gonadorelin—Fatigue—Timolol—coronary artery disease	0.000656	0.00108	CcSEcCtD
Gonadorelin—GNRHR—GPCR downstream signaling—P2RY12—coronary artery disease	0.000655	0.00179	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—PLCB3—coronary artery disease	0.000655	0.00179	CbGpPWpGaD
Gonadorelin—Headache—Trandolapril—coronary artery disease	0.000654	0.00107	CcSEcCtD
Gonadorelin—Vomiting—Telmisartan—coronary artery disease	0.000652	0.00107	CcSEcCtD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—AGT—coronary artery disease	0.000652	0.00179	CbGpPWpGaD
Gonadorelin—Asthenia—Losartan—coronary artery disease	0.000652	0.00107	CcSEcCtD
Gonadorelin—Headache—Enalapril—coronary artery disease	0.000651	0.00107	CcSEcCtD
Gonadorelin—Pain—Timolol—coronary artery disease	0.000651	0.00107	CcSEcCtD
Gonadorelin—Nausea—Niacin—coronary artery disease	0.000649	0.00107	CcSEcCtD
Gonadorelin—GNRHR—GPCR downstream signaling—CASR—coronary artery disease	0.000649	0.00178	CbGpPWpGaD
Gonadorelin—Diarrhoea—Furosemide—coronary artery disease	0.000644	0.00106	CcSEcCtD
Gonadorelin—Pruritus—Losartan—coronary artery disease	0.000643	0.00106	CcSEcCtD
Gonadorelin—Headache—Telmisartan—coronary artery disease	0.000643	0.00106	CcSEcCtD
Gonadorelin—Nausea—Pravastatin—coronary artery disease	0.000639	0.00105	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Ramipril—coronary artery disease	0.000637	0.00105	CcSEcCtD
Gonadorelin—GNRHR—Signaling by GPCR—AVPR1A—coronary artery disease	0.000636	0.00174	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—BDKRB1—coronary artery disease	0.000636	0.00174	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—GNA12—coronary artery disease	0.000636	0.00174	CbGpPWpGaD
Gonadorelin—Vomiting—Captopril—coronary artery disease	0.000634	0.00104	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—LRP8—coronary artery disease	0.000632	0.00173	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—RLN3—coronary artery disease	0.000632	0.00173	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—DGKZ—coronary artery disease	0.000632	0.00173	CbGpPWpGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—coronary artery disease	0.000628	0.00172	CbGpPWpGaD
Gonadorelin—Headache—Captopril—coronary artery disease	0.000625	0.00103	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Timolol—coronary artery disease	0.000623	0.00102	CcSEcCtD
Gonadorelin—Diarrhoea—Losartan—coronary artery disease	0.000621	0.00102	CcSEcCtD
Gonadorelin—Nausea—Trandolapril—coronary artery disease	0.00062	0.00102	CcSEcCtD
Gonadorelin—GNRHR—GPCR downstream signaling—ADM—coronary artery disease	0.000619	0.00169	CbGpPWpGaD
Gonadorelin—Nausea—Enalapril—coronary artery disease	0.000618	0.00101	CcSEcCtD
Gonadorelin—Vomiting—Perindopril—coronary artery disease	0.000616	0.00101	CcSEcCtD
Gonadorelin—Abdominal pain—Ramipril—coronary artery disease	0.000616	0.00101	CcSEcCtD
Gonadorelin—GNRHR—Signaling by GPCR—UTS2—coronary artery disease	0.000614	0.00168	CbGpPWpGaD
Gonadorelin—Gastrointestinal disorder—Lisinopril—coronary artery disease	0.00061	0.001	CcSEcCtD
Gonadorelin—Nausea—Telmisartan—coronary artery disease	0.000609	0.001	CcSEcCtD
Gonadorelin—Fatigue—Lisinopril—coronary artery disease	0.000609	0.001	CcSEcCtD
Gonadorelin—Headache—Perindopril—coronary artery disease	0.000607	0.000996	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—AES—coronary artery disease	0.000606	0.00166	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—EDN2—coronary artery disease	0.000606	0.00166	CbGpPWpGaD
Gonadorelin—Pain—Lisinopril—coronary artery disease	0.000604	0.000992	CcSEcCtD
Gonadorelin—Constipation—Lisinopril—coronary artery disease	0.000604	0.000992	CcSEcCtD
Gonadorelin—GNRHR—GPCR downstream signaling—PDE4B—coronary artery disease	0.000603	0.00165	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—F2—coronary artery disease	0.000602	0.00165	CbGpPWpGaD
Gonadorelin—Abdominal pain—Timolol—coronary artery disease	0.000602	0.000988	CcSEcCtD
Gonadorelin—Vomiting—Furosemide—coronary artery disease	0.000599	0.000983	CcSEcCtD
Gonadorelin—GNRHR—GPCR ligand binding—EDN1—coronary artery disease	0.000598	0.00164	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—PLCB3—coronary artery disease	0.000595	0.00163	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—P2RY12—coronary artery disease	0.000595	0.00163	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—CCL5—coronary artery disease	0.000593	0.00163	CbGpPWpGaD
Gonadorelin—Nausea—Captopril—coronary artery disease	0.000592	0.000973	CcSEcCtD
Gonadorelin—Headache—Furosemide—coronary artery disease	0.00059	0.000968	CcSEcCtD
Gonadorelin—GNRHR—Signaling by GPCR—CX3CR1—coronary artery disease	0.000589	0.00161	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—CASR—coronary artery disease	0.000589	0.00161	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—HRH2—coronary artery disease	0.000583	0.0016	CbGpPWpGaD
Gonadorelin—Gastrointestinal pain—Lisinopril—coronary artery disease	0.000578	0.000949	CcSEcCtD
Gonadorelin—GNRHR—Signaling by GPCR—CX3CL1—coronary artery disease	0.000578	0.00158	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—GNA12—coronary artery disease	0.000578	0.00158	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—BDKRB1—coronary artery disease	0.000578	0.00158	CbGpPWpGaD
Gonadorelin—Vomiting—Losartan—coronary artery disease	0.000577	0.000948	CcSEcCtD
Gonadorelin—Nausea—Perindopril—coronary artery disease	0.000575	0.000945	CcSEcCtD
Gonadorelin—Hypersensitivity—Ramipril—coronary artery disease	0.000574	0.000942	CcSEcCtD
Gonadorelin—Headache—Losartan—coronary artery disease	0.000569	0.000934	CcSEcCtD
Gonadorelin—GNRHR—Signaling by GPCR—PPP3R1—coronary artery disease	0.000567	0.00155	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—ADM—coronary artery disease	0.000562	0.00154	CbGpPWpGaD
Gonadorelin—Hypersensitivity—Timolol—coronary artery disease	0.000561	0.000921	CcSEcCtD
Gonadorelin—Nausea—Furosemide—coronary artery disease	0.000559	0.000918	CcSEcCtD
Gonadorelin—Asthenia—Ramipril—coronary artery disease	0.000559	0.000918	CcSEcCtD
Gonadorelin—Abdominal pain—Lisinopril—coronary artery disease	0.000558	0.000917	CcSEcCtD
Gonadorelin—GNRHR—GPCR downstream signaling—CCR3—coronary artery disease	0.000551	0.00151	CbGpPWpGaD
Gonadorelin—Pruritus—Ramipril—coronary artery disease	0.000551	0.000905	CcSEcCtD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—POMC—coronary artery disease	0.000549	0.0015	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—PDE4B—coronary artery disease	0.000547	0.0015	CbGpPWpGaD
Gonadorelin—Asthenia—Timolol—coronary artery disease	0.000546	0.000897	CcSEcCtD
Gonadorelin—Nausea—Losartan—coronary artery disease	0.000539	0.000886	CcSEcCtD
Gonadorelin—Pruritus—Timolol—coronary artery disease	0.000539	0.000885	CcSEcCtD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL2—coronary artery disease	0.000537	0.00147	CbGpPWpGaD
Gonadorelin—Diarrhoea—Ramipril—coronary artery disease	0.000533	0.000875	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—ACVR1B—coronary artery disease	0.000529	0.00145	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—RHOC—coronary artery disease	0.000529	0.00145	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—HTR2A—coronary artery disease	0.000523	0.00143	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—C3—coronary artery disease	0.000522	0.00143	CbGpPWpGaD
Gonadorelin—Diarrhoea—Timolol—coronary artery disease	0.000521	0.000856	CcSEcCtD
Gonadorelin—Hypersensitivity—Lisinopril—coronary artery disease	0.00052	0.000855	CcSEcCtD
Gonadorelin—GNRHR—GPCR downstream signaling—CXCL2—coronary artery disease	0.000518	0.00142	CbGpPWpGaD
Gonadorelin—Desmopressin—PTGS2—coronary artery disease	0.000518	0.0199	CrCbGaD
Gonadorelin—GNRHR—Signaling Pathways—NEDD4—coronary artery disease	0.000515	0.00141	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—F2R—coronary artery disease	0.000513	0.0014	CbGpPWpGaD
Gonadorelin—Asthenia—Lisinopril—coronary artery disease	0.000507	0.000832	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—PF4—coronary artery disease	0.000502	0.00137	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—MDK—coronary artery disease	0.000502	0.00137	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PDE3A—coronary artery disease	0.000502	0.00137	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—RAMP2—coronary artery disease	0.000502	0.00137	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—CCR3—coronary artery disease	0.000501	0.00137	CbGpPWpGaD
Gonadorelin—Pruritus—Lisinopril—coronary artery disease	0.0005	0.000821	CcSEcCtD
Gonadorelin—GNRHR—GPCR downstream signaling—EDNRB—coronary artery disease	0.000496	0.00136	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—AGT—coronary artery disease	0.000496	0.00136	CbGpPWpGaD
Gonadorelin—Vomiting—Ramipril—coronary artery disease	0.000495	0.000813	CcSEcCtD
Gonadorelin—Headache—Ramipril—coronary artery disease	0.000488	0.000801	CcSEcCtD
Gonadorelin—Vomiting—Timolol—coronary artery disease	0.000484	0.000795	CcSEcCtD
Gonadorelin—Diarrhoea—Lisinopril—coronary artery disease	0.000483	0.000794	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—NPY5R—coronary artery disease	0.000479	0.00131	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—F2RL1—coronary artery disease	0.000479	0.00131	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—RALBP1—coronary artery disease	0.000479	0.00131	CbGpPWpGaD
Gonadorelin—Headache—Timolol—coronary artery disease	0.000477	0.000783	CcSEcCtD
Gonadorelin—GNRHR—Signaling by GPCR—CXCL2—coronary artery disease	0.000471	0.00129	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—CCL3—coronary artery disease	0.000471	0.00129	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—EDNRA—coronary artery disease	0.000469	0.00128	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—ADRB1—coronary artery disease	0.000467	0.00128	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—F2R—coronary artery disease	0.000466	0.00128	CbGpPWpGaD
Gonadorelin—Nausea—Ramipril—coronary artery disease	0.000463	0.00076	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—FZD2—coronary artery disease	0.000459	0.00126	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—UTS2R—coronary artery disease	0.000459	0.00126	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—F2—coronary artery disease	0.000459	0.00126	CbGpPWpGaD
Gonadorelin—Nausea—Timolol—coronary artery disease	0.000452	0.000743	CcSEcCtD
Gonadorelin—GNRHR—Signaling by GPCR—EDNRB—coronary artery disease	0.000451	0.00123	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—SFRP2—coronary artery disease	0.00045	0.00123	CbGpPWpGaD
Gonadorelin—Vomiting—Lisinopril—coronary artery disease	0.000449	0.000738	CcSEcCtD
Gonadorelin—Headache—Lisinopril—coronary artery disease	0.000442	0.000727	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—ADORA3—coronary artery disease	0.000442	0.00121	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—APOA4—coronary artery disease	0.000442	0.00121	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—ADORA1—coronary artery disease	0.000442	0.00121	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—BDKRB2—coronary artery disease	0.000441	0.00121	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—CXCL12—coronary artery disease	0.000441	0.00121	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—PLCB1—coronary artery disease	0.000431	0.00118	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PGF—coronary artery disease	0.000427	0.00117	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PPBP—coronary artery disease	0.000427	0.00117	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—EDNRA—coronary artery disease	0.000426	0.00117	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCL8—coronary artery disease	0.000424	0.00116	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—ADRB1—coronary artery disease	0.000424	0.00116	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—HTR7—coronary artery disease	0.000422	0.00116	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—ITGA2B—coronary artery disease	0.00042	0.00115	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—DVL1—coronary artery disease	0.00042	0.00115	CbGpPWpGaD
Gonadorelin—Nausea—Lisinopril—coronary artery disease	0.00042	0.000689	CcSEcCtD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—coronary artery disease	0.000419	0.00115	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—POMC—coronary artery disease	0.000418	0.00114	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—CCL2—coronary artery disease	0.000409	0.00112	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—OPRD1—coronary artery disease	0.000407	0.00112	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CCL4—coronary artery disease	0.000407	0.00112	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—GHR—coronary artery disease	0.000407	0.00112	CbGpPWpGaD
Gonadorelin—GNRHR—G alpha (q) signalling events—PIK3CA—coronary artery disease	0.000407	0.00111	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—KNG1—coronary artery disease	0.000401	0.0011	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—BDKRB2—coronary artery disease	0.0004	0.0011	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—CXCL12—coronary artery disease	0.0004	0.0011	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—AGTR1—coronary artery disease	0.000399	0.00109	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—PLCB1—coronary artery disease	0.000392	0.00107	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—TLE4—coronary artery disease	0.00039	0.00107	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—MEF2A—coronary artery disease	0.00039	0.00107	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—CXCL10—coronary artery disease	0.00039	0.00107	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—HTR7—coronary artery disease	0.000383	0.00105	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—APOA2—coronary artery disease	0.00038	0.00104	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—ADRB2—coronary artery disease	0.000378	0.00104	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—AVPR1A—coronary artery disease	0.000376	0.00103	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—PRKCE—coronary artery disease	0.000373	0.00102	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—KNG1—coronary artery disease	0.000364	0.000998	CbGpPWpGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—coronary artery disease	0.000364	0.000996	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—UTS2—coronary artery disease	0.000363	0.000994	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—AGTR1—coronary artery disease	0.000362	0.000992	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—NR4A1—coronary artery disease	0.000355	0.000973	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—CXCL10—coronary artery disease	0.000354	0.000969	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—P2RY12—coronary artery disease	0.000351	0.000963	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—HDAC9—coronary artery disease	0.000351	0.000963	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PLCB3—coronary artery disease	0.000351	0.000963	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CX3CR1—coronary artery disease	0.000348	0.000953	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CASR—coronary artery disease	0.000348	0.000953	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—ADRB2—coronary artery disease	0.000343	0.000941	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—GNA12—coronary artery disease	0.000341	0.000934	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—P4HB—coronary artery disease	0.000341	0.000934	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—BDKRB1—coronary artery disease	0.000341	0.000934	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CX3CL1—coronary artery disease	0.000341	0.000934	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—PRKCE—coronary artery disease	0.000339	0.000929	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—EDN1—coronary artery disease	0.000338	0.000926	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—CCL5—coronary artery disease	0.000335	0.000919	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PPP3R1—coronary artery disease	0.000335	0.000917	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—ADM—coronary artery disease	0.000332	0.000909	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—CSF2—coronary artery disease	0.00033	0.000905	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PDE4B—coronary artery disease	0.000323	0.000886	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CYBB—coronary artery disease	0.000323	0.000886	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—CXCL8—coronary artery disease	0.000323	0.000885	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—MMP3—coronary artery disease	0.000323	0.000884	CbGpPWpGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—coronary artery disease	0.000322	0.000882	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—EDN1—coronary artery disease	0.000307	0.000841	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—CCL5—coronary artery disease	0.000305	0.000834	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—PRKCD—coronary artery disease	0.000302	0.000828	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—CSF2—coronary artery disease	0.0003	0.000822	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CCR3—coronary artery disease	0.000296	0.00081	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—HTR2A—coronary artery disease	0.000296	0.00081	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—C3—coronary artery disease	0.000295	0.000809	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CRK—coronary artery disease	0.000292	0.0008	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—ATP2A2—coronary artery disease	0.000288	0.00079	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—SH2B3—coronary artery disease	0.000288	0.00079	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—VWF—coronary artery disease	0.000288	0.00079	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—APOC3—coronary artery disease	0.000286	0.000785	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—LDLR—coronary artery disease	0.000285	0.00078	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—AGT—coronary artery disease	0.000281	0.000768	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—PPP2CA—coronary artery disease	0.000279	0.000765	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CXCL2—coronary artery disease	0.000278	0.000762	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CCL3—coronary artery disease	0.000278	0.000762	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—F2R—coronary artery disease	0.000275	0.000753	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—SDC1—coronary artery disease	0.000275	0.000753	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—PRKCD—coronary artery disease	0.000274	0.000751	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—FGB—coronary artery disease	0.000269	0.000737	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—HTR2A—coronary artery disease	0.000268	0.000735	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—C3—coronary artery disease	0.000268	0.000734	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—EDNRB—coronary artery disease	0.000266	0.000729	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—THBS1—coronary artery disease	0.000262	0.000719	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PSMA6—coronary artery disease	0.00026	0.000712	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PSMB5—coronary artery disease	0.00026	0.000712	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—F2—coronary artery disease	0.000259	0.00071	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—AGT—coronary artery disease	0.000255	0.000698	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—EDNRA—coronary artery disease	0.000252	0.000689	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CYBA—coronary artery disease	0.00025	0.000686	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—ADRB1—coronary artery disease	0.00025	0.000686	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—DUSP6—coronary artery disease	0.000249	0.000683	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PLAT—coronary artery disease	0.000245	0.000671	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—BDKRB2—coronary artery disease	0.000236	0.000648	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CXCL12—coronary artery disease	0.000236	0.000648	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—POMC—coronary artery disease	0.000236	0.000647	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—F2—coronary artery disease	0.000235	0.000645	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—IL6ST—coronary artery disease	0.000234	0.000642	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—JUNB—coronary artery disease	0.000232	0.000636	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PLCB1—coronary artery disease	0.000231	0.000633	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—HTR7—coronary artery disease	0.000226	0.00062	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—ITGAV—coronary artery disease	0.000216	0.000591	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—KNG1—coronary artery disease	0.000215	0.000589	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—POMC—coronary artery disease	0.000214	0.000587	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—CREB1—coronary artery disease	0.000214	0.000587	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—AGTR1—coronary artery disease	0.000214	0.000586	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—CCL2—coronary artery disease	0.00021	0.000575	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—IL6R—coronary artery disease	0.000209	0.000573	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CXCL10—coronary artery disease	0.000209	0.000572	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PLG—coronary artery disease	0.000208	0.000571	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—ADRB2—coronary artery disease	0.000203	0.000556	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PRKCE—coronary artery disease	0.0002	0.000549	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—JAK2—coronary artery disease	0.0002	0.000548	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—SOCS1—coronary artery disease	0.0002	0.000547	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—S100B—coronary artery disease	0.000199	0.000546	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—SOCS3—coronary artery disease	0.000197	0.000541	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—KITLG—coronary artery disease	0.000195	0.000534	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—TGFBR2—coronary artery disease	0.000195	0.000534	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—STAT5A—coronary artery disease	0.000191	0.000522	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—MMP3—coronary artery disease	0.000191	0.000522	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—APOB—coronary artery disease	0.000184	0.000505	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—CXCL8—coronary artery disease	0.000183	0.0005	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—JAK2—coronary artery disease	0.000182	0.000498	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—EDN1—coronary artery disease	0.000181	0.000497	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CCL5—coronary artery disease	0.00018	0.000493	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—FGF1—coronary artery disease	0.000177	0.000485	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CSF2—coronary artery disease	0.000177	0.000485	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—LPL—coronary artery disease	0.000176	0.000482	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—RPS6KB1—coronary artery disease	0.000174	0.000478	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—MEF2C—coronary artery disease	0.000174	0.000478	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—ITGB3—coronary artery disease	0.00017	0.000465	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—CXCL8—coronary artery disease	0.000166	0.000454	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PPP2CA—coronary artery disease	0.000165	0.000452	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PRKCD—coronary artery disease	0.000162	0.000444	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—HTR2A—coronary artery disease	0.000159	0.000434	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—C3—coronary artery disease	0.000158	0.000434	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—HIF1A—coronary artery disease	0.000151	0.000414	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—AGT—coronary artery disease	0.00015	0.000412	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—APOE—coronary artery disease	0.000147	0.000404	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—LEP—coronary artery disease	0.000147	0.000404	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—APOA1—coronary artery disease	0.000146	0.000399	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—KDR—coronary artery disease	0.000144	0.000396	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—MAPK14—coronary artery disease	0.000144	0.000393	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—ESR1—coronary artery disease	0.000141	0.000386	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—F2—coronary artery disease	0.000139	0.000381	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—FN1—coronary artery disease	0.000139	0.000381	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—IL6ST—coronary artery disease	0.000138	0.000379	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—NFKBIA—coronary artery disease	0.000137	0.000376	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—KIT—coronary artery disease	0.000133	0.000364	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—GSK3B—coronary artery disease	0.000128	0.00035	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CREB1—coronary artery disease	0.000127	0.000347	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—POMC—coronary artery disease	0.000127	0.000347	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CCL2—coronary artery disease	0.000124	0.000339	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—IL6R—coronary artery disease	0.000124	0.000338	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—IGF1—coronary artery disease	0.000122	0.000334	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—MAPK1—coronary artery disease	0.000121	0.000332	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—PIK3CA—coronary artery disease	0.000116	0.000317	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—SERPINE1—coronary artery disease	0.000116	0.000317	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—FGF2—coronary artery disease	0.000112	0.000307	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—NOS3—coronary artery disease	0.00011	0.000303	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—JAK2—coronary artery disease	0.000107	0.000294	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—PIK3CA—coronary artery disease	0.000105	0.000288	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CXCL8—coronary artery disease	9.8e-05	0.000268	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—AKT1—coronary artery disease	9.47e-05	0.000259	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CASP3—coronary artery disease	9.38e-05	0.000257	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—IL6—coronary artery disease	9.32e-05	0.000255	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CCND1—coronary artery disease	9.13e-05	0.00025	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—MMP9—coronary artery disease	8.86e-05	0.000243	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—AKT1—coronary artery disease	8.6e-05	0.000235	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—VEGFA—coronary artery disease	7.96e-05	0.000218	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—TGFB1—coronary artery disease	7.3e-05	0.0002	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—MAPK1—coronary artery disease	7.16e-05	0.000196	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—PIK3CA—coronary artery disease	6.22e-05	0.00017	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—IL6—coronary artery disease	5.5e-05	0.000151	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—AKT1—coronary artery disease	5.08e-05	0.000139	CbGpPWpGaD
